ArticleJournal of conservative dentistry and endodontics2025
Comparison between biodentine and light-cured mineral trioxide aggregate as an indirect pulp capping agent - A randomized controlled trial.
Article in Journal of conservative dentistry and endodontics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Novel acemannan-integrated bioceramic for enhancing human dental pulp stem cell viability and transforming growth factor beta-1 release in pulp regeneration.Journal of conservative dentistry and endodontics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Indirect pulp capping (IPC) represents a pivotal therapeutic intervention directed toward preservation of pulp vitality, achieved through the placement of a biocompatible, bioactive material over the affected dentin to protect the pulp from further insult and encourage healing. Aim: This study aimed to evaluate the clinical and radiographical success rates of Biodentin versus light-cured mineral trioxide aggregate (MTA) when used as an IPC agents. Evaluation was done on the basis of prognosis of the treatment after a period of 1 year. Methodology: This randomized controlled clinical trial was based on a cohort of 20 individuals with deep carious lesions being subsequently divided into two experimental groups of ten cases each. Group I - Biodentin and Group II - Light cured-MTA as pulp capping agents, respectively. Clinical and radiographical assessment was done at baseline, 1, 2, 3, 6 months, and 1 year. Results: Statistical analysis with the Chi-square test showed no statistically significant difference between the groups. The overall success rate of 1-year follow-up for both Biodentine group and Light-cured MTA group was 93.33%. Conclusion: The results of this randomized controlled clinical trial support promising success of IPC independent of the pulp capping material used as the findings underscore a significant decrease in postoperative pain levels compared to preoperative states across all cases. However, more studies with long-term follow-ups are required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.